Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Bowdoin Square
6th Floor
Boston, MA 02114Phone+1 617-643-4682Fax+1 888-369-9112
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 2008 - 2012
- Harvard-MIT Division of Health Sciences and TechnologyMD / Honors in a Special Field, Neurophysiology, Cum Laude, 2002 - 2008
- Harvard Medical SchoolClass of 2006
- Brown UniversityBS, Neuroscience, Magna Cum Laude, 1996 - 2000
Certifications & Licensure
- CA State Medical License 2010 - Present
- MA State Medical License 2018 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers Start of enrollment: 2014 Apr 01
- Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment Start of enrollment: 2014 Apr 01
- Group Therapy for Depressed Dementia Caregivers Start of enrollment: 2017 Mar 01
Publications & Presentations
PubMed
- 54 citationsProspective assessment of stereotactic ablative surgery for intractable major depression.Donald C. Shields, Wael F. Asaad, Emad N. Eskandar, Felipe A. Jain, G. Rees Cosgrove
Biological Psychiatry. 2008-09-15 - 11 citationsFour-Week Mentalizing Imagery Therapy for Family Dementia Caregivers: A Randomized Controlled Trial with Neural Circuit Changes.Felipe A Jain, Sergey V Chernyak, Lisa D Nickerson, Stefana Morgan, Rhiana Schafer
Psychotherapy and Psychosomatics. 2022-01-01 - 303 citationsOxidative stress, inflammation and treatment response in major depressionDaniel Lindqvist, Firdaus S. Dhabhar, S. Jill James, Christina M. Hough, Felipe A. Jain
Psychoneuroendocrinology. 2017-02-01
Press Mentions
- Novel Therapy Reduces Depression in Family CaregiversMarch 15th, 2022
- FDA Panel Backs Sage’s Postpartum Depression Drug in 17-1 VoteNovember 5th, 2018
- FDA Panel Slams Alkermes’ Opioid-Based Depression DrugNovember 2nd, 2018
- Join now to see all
Other Languages
- Spanish
External Links
- Personal Homepagehttp://www.felipejain.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: